Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

33.16
-0.1300-0.39%
Post-market: 33.160.00000.00%17:53 EST
Volume:989.06K
Turnover:33.07M
Market Cap:5.48B
PE:16.44
High:34.27
Open:33.52
Low:33.09
Close:33.29
52wk High:36.45
52wk Low:25.17
Shares:165.12M
Float Shares:162.42M
Volume Ratio:0.61
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.02
EPS(LYR):2.17
ROE:22.35%
ROA:9.99%
PB:3.16
PE(LYR):15.28

Loading ...

BRIEF-Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market

Reuters
·
Feb 12

Avadel Pharmaceuticals Shares Delisted from Nasdaq Following Acquisition

Reuters
·
Feb 12

Alkermes Completes Acquisition of Avadel Pharmaceuticals

Reuters
·
Feb 12

Alkermes Plc - Deal Expected to Be Accretive in 2026

THOMSON REUTERS
·
Feb 12

Alkermes Plc Completes Acquisition of Avadel Pharmaceuticals Plc, Accelerating Entry Into Sleep Medicine Market

THOMSON REUTERS
·
Feb 12

Alkermes plc to Report Financial Results and Outline 2026 Expectations

Reuters
·
Feb 12

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026

THOMSON REUTERS
·
Feb 12

Irish Court Approves Avadel Pharmaceuticals Acquisition by Alkermes

Reuters
·
Feb 11

Alkermes EVP and Chief Medical Officer Craig C. Hopkinson Reports Disposal of Common Shares

Reuters
·
Feb 03

Irish Court Sets Date to Sanction Avadel Pharmaceuticals Acquisition by Alkermes

Reuters
·
Jan 20

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Lexicon Pharmaceuticals (LXRX) and Alkermes (ALKS)

TIPRANKS
·
Jan 16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Alkermes (ALKS) and Apellis Pharmaceuticals (APLS)

TIPRANKS
·
Jan 13

Avadel Shareholders Approve Acquisition by Alkermes

Reuters
·
Jan 13

Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson Reports Disposal of Common Shares

Reuters
·
Jan 09

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

Reuters
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Reuters
·
Jan 06

BUZZ-Alkermes rises as narcolepsy drug gets FDA breakthrough tag

Reuters
·
Jan 06

Alkermes Shares up 2.9% Premarket After US FDA Grants Breakthrough Therapy Designation for Its Sleep Disorder Treatment

THOMSON REUTERS
·
Jan 06

FDA Grants Breakthrough Therapy Designation to Alkermes' Alixorexton for Narcolepsy Type 1

Reuters
·
Jan 06

Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1

THOMSON REUTERS
·
Jan 06